[Innovations with system disrupting potential? New drugs of high value].
Pfannkuche
Matthias S
MS
Universität Bremen, ZeS, Ausser der Schleifmühle 35-37, 28203 Bremen. pfannkuche@zes.uni-bremen.de
Glaeske
Gerd
G
D003362:Cost-Benefit Analysis; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000191:economics*; D047428:Protein Kinase Inhibitors / Q000191:economics* / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D016032:Randomized Controlled Trials as Topic
D047428:Protein Kinase Inhibitors; D011505:Protein-Tyrosine Kinases